Debt is an inevitable reality for most businesses, a necessary tool for growth and expansion. However, left unchecked, mounting debt obligations can strangle even the most promising of companies. Confronting and[…]
Tübingen-based biotech company, Acousia Therapeutics GmbH, has announced the randomization of the first patient for their PROHEAR-Study on February 15, 2024. The study, which is a placebo-controlled, Phase 2a trial with[…]
German and European Union citizens are showing increasing concern for the situation in Ukraine as the 2024 election year approaches in both the EU and the US. According to a recent[…]